Plasmatic Levels and Response to Variable Doses of Monthly Aripiprazole and Three-Month Paliperidone in Patients with Severe Schizophrenia. Treatment Adherence, Effectiveness, Tolerability, and Safety

MLA

Fernández-Miranda JJ, and Díaz-Fernández S. “Plasmatic Levels and Response to Variable Doses of Monthly Aripiprazole and Three-Month Paliperidone in Patients with Severe Schizophrenia. Treatment Adherence, Effectiveness, Tolerability, and Safety.” Neuropsychiatric Disease and Treatment, vol. ume 19, Oct. 2023, pp. 2093–103. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.957403409a924e228246a5ab9d6e638f&authtype=sso&custid=ns315887.

APA

Fernández-Miranda JJ, & Díaz-Fernández S. (2023). Plasmatic Levels and Response to Variable Doses of Monthly Aripiprazole and Three-Month Paliperidone in Patients with Severe Schizophrenia. Treatment Adherence, Effectiveness, Tolerability, and Safety. Neuropsychiatric Disease and Treatment, ume 19, 2093–2103.

Chicago

Fernández-Miranda JJ, and Díaz-Fernández S. 2023. “Plasmatic Levels and Response to Variable Doses of Monthly Aripiprazole and Three-Month Paliperidone in Patients with Severe Schizophrenia. Treatment Adherence, Effectiveness, Tolerability, and Safety.” Neuropsychiatric Disease and Treatment ume 19 (October): 2093–2103. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.957403409a924e228246a5ab9d6e638f&authtype=sso&custid=ns315887.